Current Oncology Reports

Papers
(The TQCC of Current Oncology Reports is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer170
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review112
Brain Prehabilitation for Oncologic Surgery98
Surgical Management of Melanoma: Advances and Updates81
Immunotherapy in Biliary Tract Cancers: Where Are We?62
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas51
New Developments in VHL-Associated Neuroendocrine Neoplasms50
NRG1 Fusions: The New Kid on the Block49
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review48
“What Should I Eat?”—Addressing Questions and Challenges Related to Nutrition in the Integrative Oncology Setting45
The Microbiome in Advanced Melanoma: Where Are We Now?45
Surgical Stress and Cancer Progression: New Findings and Future Perspectives43
Head and Neck Mucosal Melanoma: Where Are We Now?39
Current Trends and Challenges of Microbiome Research in Prostate Cancer39
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan38
Cellular Therapy in NSCLC: Between Myth and Reality38
AXL Inhibitors: Status of Clinical Development38
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients37
The Difficult Airway in Patients with Cancer37
An Overview of Angiogenesis in Bladder Cancer36
Appendiceal Neuroendocrine Neoplasms: an Update for 202334
Targeting the PI3K Pathway in Gynecologic Malignancies33
Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision—a Literature Review32
Novel Surgical Initiatives in Gastroenteropancreatic Neuroendocrine Tumours30
Proton Therapy in The Treatment of Head And Neck Cancers- Review30
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?29
CAR-T Therapies in Solid Tumors: Opportunities and Challenges28
Breast cancer Treatment and Fertility Preservation: A Narrative Review of Impacts, Strategies and Ethical Considerations28
Geographical Disparities in Colorectal Cancer in Canada: A Review27
Biomarkers in the Immuno-oncology Interface of Triple Negative Breast Cancer: A Scoping Review with Perioperative Considerations26
Use of Circulating Tumor DNA to Guide Decision-making in Adjuvant Colon Cancer26
Diagnostic Accuracy of Liquid Biopsy for Oral Potentially Malignant Disorders and Head and Neck Cancer: an Overview of Systematic Reviews26
Development of Effective Siglec-9 Antibodies Against Cancer24
Surgical Management of the Primary Tumor in Stage IV Small Intestinal Neuroendocrine Tumors: To Operate or Not to Operate, That Is the Question24
A Systematic Review and a Meta-analysis of Randomized Controlled Trials’ Control Groups in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)24
Pre- and Post-Microsurgical Rehabilitation Interventions and Outcomes on Breast Cancer–Related Lymphedema: a Systematic Review23
Surgery for Recurrent Epithelial Ovarian Cancer23
Antibody-Drug Conjugates in Breast Cancer: The Road Towards Biologically-Informed Selection and Sequencing23
Vascular Inflammation, Cancer, and Cardiovascular Diseases23
Role of the Microbiome and Diet for Response to Cancer Checkpoint Immunotherapy: A Narrative Review of Clinical Trials23
Current Management of Neuroendocrine Tumour Liver Metastases22
Inequities Among Cancer Caregivers with Diverse Identities: A Review of the Literature and Future Directions22
Dedifferentiated Chondrosarcoma: Diagnostic Controversies and Emerging Therapeutic Targets22
Evolving Role of CAR T Cell Therapy in First- and Second-Line Treatment of Large B Cell Lymphoma22
The Evidence for Using Artificial Intelligence to Enhance Prostate Cancer MR Imaging21
Current Diagnostic Tools for Breast Cancer-Related Lymphedema21
Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?21
Management of Peripheral T-cell Lymphomas and the Role of Transplant20
Elderly Rectal Cancer: An Updated Review20
Small Cell and Other Rare Histologic Types of Cervical Cancer20
Advancements in the Diagnosis, Treatment, and Risk Stratification of Non-Muscle Invasive Bladder Cancer20
History of Leukemia, Revisited19
Therapeutic Management in Elderly Male Breast Cancer Patients: A Scoping Review19
Multimodality Therapies for Localized Prostate Cancer19
Current Status on Management of Primary Plasma Cell Leukemia19
Human Epidermal Growth Factor Receptor 2 Positive Advanced Gastric or Esophagogastric Adenocarcinoma: Reflecting on the Past to Gain a New Insights19
Epidemiology of Cancer in Older Adults: A Systematic Review18
Integrative Medicine Across the Pediatric Cancer Care Trajectory: A Narrative Review18
Unveiling the Hidden Links: Periodontal Disease, Fusobacterium Nucleatum, and Cancers18
Intratumoral Immunotherapy: Is It Ready for Prime Time?18
Return to Intended Oncological Therapy: State of the Art and Perspectives17
Management of Pathologic Node-Positive Prostate Cancer following Radical Prostatectomy17
Limb Amputations in Cancer: Modern Perspectives, Outcomes, and Alternatives17
Blood–Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade17
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development17
Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours17
Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions17
Cured or Not? Long-term Outcomes of Immunotherapy Responders. Focus on Melanoma17
Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis17
Nasal Cavity and Paranasal Sinus Cancer: Diagnosis and Treatment17
CDK4/6 inhibitors: The Devil is in the Detail16
Racial Disparities in Breast Cancer: from Detection to Treatment16
15 Years Old ALK Gene from Birth to Adolescence; Where to in NBL16
Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas16
Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer16
Prevention of Ovarian Cancer: Where are We Now and Where are We Going?16
All-Cause Mortality Risk Prediction in Older Adults with Cancer: Practical Approaches and Limitations15
Cardio-Oncology in Childhood: State of the Art15
Oral Health in Patients with History of Head and Neck Cancer: Complexity and Benefits of a Targeted Oral Healthcare Pathway15
Advances in Treatment of Waldenström Macroglobulinemia15
Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer15
CAR T-cell Therapy for Central Nervous System Lymphoma15
Use of Antihyperglycemic Drugs and Risk of Cancer in Patients with Diabetes15
Radiogenomics as an Integrated Approach to Glioblastoma Precision Medicine15
Resectability versus Operability in Early-Stage Non-Small Cell Lung Cancer15
Epidemiology of cancer in older adults: a systematic review of age-related differences in solid malignancies treatment15
Lymphatic Mapping and Sentinel Node Biopsy in High-Grade Uterine Cancers14
Fertility-Sparing and Less Radical Surgery for Cervical Cancer14
Pelvic Floor Therapy and Initial Interventions for Pelvic Floor Dysfunction in Gynecologic Malignancies14
Integrative Geriatric Oncology: A Review of Current Practices14
Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism14
Traditional Chinese Medicine Herbs for Breast Cancer Prevention and Survival: A Narrative Review of Epidemiological Studies from Taiwan14
Surviving Burnout as an Oncologist14
New Developments in Image-Guided Percutaneous Irreversible Electroporation of Solid Tumors14
Correction: Enhanced Recovery in Gynecologic Oncology Surgery—State of the Science14
Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis14
Intracranial Germinomas: Diagnosis, Pathogenesis, Clinical Presentation, and Management14
Options for Rescue Treatment of Patients with AL Amyloidosis Exposed to Upfront Daratumumab14
0.06765604019165